Julie A Johnson Selected Research

Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)

2/2024	Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
1/2019	Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
8/2013	Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
9/2010	Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
10/2009	Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Johnson Research Topics

Disease

57	Hypertension (High Blood Pressure) 02/2024 - 07/2003
13	Myocardial Infarction 01/2022 - 06/2007
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 06/2007
11	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 12/2002
11	Stroke (Strokes) 01/2021 - 09/2007
10	Heart Failure 09/2011 - 10/2003
8	Essential Hypertension 03/2016 - 09/2010
5	Hyperglycemia 01/2018 - 10/2009
4	Pain (Aches) 10/2022 - 01/2019
4	Ischemic Stroke 08/2022 - 01/2017
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 06/2011
4	Hemorrhage 01/2022 - 09/2013
4	Diabetes Mellitus 01/2022 - 10/2009
3	Chronic Renal Insufficiency 04/2024 - 01/2019
3	Gastroesophageal Reflux (GERD) 01/2023 - 01/2021
3	Thrombosis (Thrombus) 01/2022 - 11/2020
3	Inflammation (Inflammations) 01/2021 - 06/2011
3	Neoplasms (Cancer) 01/2018 - 10/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015 - 01/2012
2	Esophagitis 01/2023 - 01/2021
2	Postoperative Pain 10/2022 - 01/2021
2	Unstable Angina 01/2022 - 01/2022
2	Chronic Pain 12/2021 - 01/2019
2	Hypokalemia 01/2021 - 10/2009
2	Infections 01/2021 - 01/2019
2	Atherosclerosis 01/2021 - 07/2017
2	Acute Coronary Syndrome 10/2020 - 04/2011
2	Invasive Fungal Infections 01/2017 - 07/2014
2	Chronic Disease (Chronic Diseases) 01/2013 - 06/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2008 - 03/2008
1	Acute Pain 10/2022
1	Opioid-Related Disorders (Opiate Addiction) 10/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2022
1	Duodenal Ulcer (Curling's Ulcer) 01/2021
1	Hyperuricemia 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2020
1	Rupture 11/2020

Drug/Important Bio-Agent (IBA)

35	Antihypertensive Agents (Antihypertensives)IBA 02/2024 - 07/2003
13	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2022 - 10/2009
12	Atenolol (Tenormin)FDA LinkGeneric 10/2016 - 01/2010
11	Verapamil (Calan)FDA LinkGeneric 01/2019 - 06/2007
10	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 06/2007
8	Cytochrome P-450 CYP2C19IBA 04/2024 - 07/2014
8	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022 - 07/2003
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2012
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2009
5	Clopidogrel (Plavix)FDA Link 04/2024 - 05/2015
5	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 02/2024 - 10/2009
5	ThiazidesIBA 02/2024 - 10/2009
5	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2022 - 12/2004
4	Chlorthalidone (Chlortalidone)FDA LinkGeneric 12/2022 - 12/2017
4	Opioid Analgesics (Opioids)IBA 10/2022 - 01/2019
4	DiureticsIBA 01/2021 - 08/2008
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021 - 06/2007
3	MicroRNAs (MicroRNA)IBA 02/2024 - 03/2016
3	AcidsIBA 01/2023 - 04/2014
3	Proton Pump InhibitorsIBA 01/2023 - 01/2021
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2007
3	ReninIBA 11/2019 - 01/2007
3	CholesterolIBA 01/2019 - 06/2011
3	Diltiazem (Cardizem)FDA LinkGeneric 06/2015 - 07/2013
3	beta Adrenergic ReceptorsIBA 05/2015 - 12/2002
3	Codon (Codons)IBA 04/2005 - 07/2003
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2017
2	PotassiumIBA 01/2021 - 10/2009
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 07/2014
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2019
2	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 07/2014
2	Bisoprolol (Concor)FDA LinkGeneric 11/2015 - 05/2010
2	Amino Acids FDA Link 06/2015 - 04/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 04/2013
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2015 - 03/2008
2	EnzymesIBA 07/2014 - 12/2010
2	HDL LipoproteinsIBA 01/2013 - 01/2010
2	Carvedilol (Coreg)FDA LinkGeneric 12/2011 - 05/2010
2	Warfarin (Coumadin)FDA LinkGeneric 09/2011 - 03/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2009 - 04/2008
1	Circulating MicroRNAIBA 02/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2024
1	Lysine (L-Lysine)FDA Link 02/2024
1	Complement System Proteins (Complement)IBA 08/2022
1	Blood Group Antigens (Blood Groups)IBA 08/2022
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2022
1	TabletsIBA 01/2022
1	Opiate AlkaloidsIBA 12/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021
1	Ondansetron (Zofran)FDA LinkGeneric 12/2021
1	NLR ProteinsIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	IsoenzymesIBA 01/2021
1	InflammasomesIBA 01/2021
1	factor V LeidenIBA 11/2020
1	Sorting NexinsIBA 01/2020

Therapy/Procedure

32	Therapeutics 04/2024 - 03/2005
3	Percutaneous Coronary Intervention 01/2022 - 05/2015
3	Secondary Prevention 01/2019 - 05/2015
2	Precision Medicine 01/2023 - 07/2013
2	Stents 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 06/2011 - 08/2006
1	Operative Surgical Procedures 10/2022